Naslov
Genetically modified and immunologically attenuated herpesviruses as potent vaccine vectors.

Autori
Jonjić, Stipan

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Skup
Power of Viral Vectors in Gene Therapy and Basic Science Summer School

Mjesto i datum
Primošten, Hrvatska, 17.09.2014. - 21.09.2014

Vrsta sudjelovanja
Pozvano predavanje

Vrsta recenzije
Domaća recenzija

Ključne riječi
vaccine vectors; NKG2D; Rae-1 gamma; CD8 T cells

Sažetak
Cytomegalovirus (CMV) establishes life-long infection of its host, ensuring continuous supply of effector memory CD8+ T cells. CMVs possess numerous immunoevasion genes able to modulate basically any part of immune response, including NK cell and CD8+ T cell response. It is well established that deletion of these viral inhibitors leads to virus attenuation in vivo.These features make CMV a very attractive CD8+ T cell vaccine-vector candidate. Control of CMV infection is in great part dependent on NKG2D, an activating receptor when expressed on NK cells and co-stimulatory one when expressed on CD8+ T cells. We have constructed highly attenuated mouse CMV (MCMV) expressing NKG2D ligand RAE-1γ inserted in place of its viral inhibitor (Slavuljica et al, 2010) and foreign CD8+ T cell epitope as well (Trsan et al, 2013). Such a recombinant vaccine-vector provided outstanding and long-lasting CD8+ T cell-mediated protection against challenge infections. Moreover, RAE-1γMCMV-vector circumvented MCMV interference of antigen presentation, improved antigen presentation to CD8+ T cells and potentiated memory CD8+ T cell response. Outstanding properties of RAE-1γ expressing MCMV vector were retained even in NKG2D deficient mice, pointing to additional NKG2D-independent immune function of RAE-1γ.

Izvorni jezik
Engleski

POVEZANOST RADA